[
  {
    "tier": "Tier 1",
    "company": "Lonza",
    "hq_country": "Switzerland",
    "industry": "Pharma & Life Sciences",
    "revenue": "Approx. $6B",
    "situations": "Margin Pressure, Significant Growth, Supply Chain Disruption",
    "classification": "Likely, Likely, Likely",
    "priority_score": "RC: 0",
    "key_evidence": "MP: 5",
    "sources": "SG: 4",
    "_score_int": 0,
    "_frequency": 1
  },
  {
    "tier": "Tier 1",
    "company": "Sika",
    "hq_country": "Switzerland",
    "industry": "Chemicals",
    "revenue": "Approx. $11B",
    "situations": "Significant Growth, Supply Chain Disruption",
    "classification": "Confirmed, Likely",
    "priority_score": "RC: 0",
    "key_evidence": "MP: 0",
    "sources": "SG: 8",
    "_score_int": 0,
    "_frequency": 1
  }
]